Brief: Aequus announces positive results for proof of concept clinical trial of anti-nausea patch
07/09/2017 18:23
Sept 7 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus announces positive results for proof of concept
clinical trial of anti-nausea patch
* Says formulation was well tolerated with no serious
adverse events reported
* Says co owns global rights to program,will look to find a
strategic partner to advance towards commercialization in major
markets
Source text for Eikon: ID:nCCNLq6DSa
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange